---
source_pdf_path: Resources/Artificial Intelligence in Cerebrovascular Disease Management  A Comprehensive Review of Risk Prediction  Diagnosis  Therapeutic Optimization  and Cli.pdf
slug: zhang-2025-cerebrovascular-ai
ledger_status: TRIAGED
---

# zhang-2025-cerebrovascular-ai

## Bibliographic
- Title: Artificial Intelligence in Cerebrovascular Disease Management: A Comprehensive Review of Risk Prediction, Diagnosis, Therapeutic Optimization, and Clinical Translation
- First author / authors (first 3 + et al.): Hengsheng Zhang, Wenhui Ma, Xingshun Zhou, et al.
- Year: 2025
- Venue: Vascular Health and Risk Management
- DOI: 10.2147/VHRM.S555592

## One-line claim
This review synthesizes AI advancements in cerebrovascular disease management across risk prediction, diagnosis, therapeutic optimization, and long-term monitoring, proposing solutions to barriers in clinical translation.

## T6 targeted questions
- **Q-A geometry perturbation**: Does not directly perturb or measure lumen/segmentation uncertainty in the context of error injection or inter-observer disagreement quantification. Mentions segmentation accuracy (Dice=0.94 for hemorrhage) but not inter-observer variability magnitudes.
- **Q-B decision flip**: NOT REPORTED for FFR-specific threshold. The paper mentions "door-to-needle time" (DNT) in thrombolysis and diagnostic reclassification in general clinical terms, but does not report FFR ≤0.80 or similar diagnostic decision flip rates.
- **Q-C BC tuning**: NOT REPORTED. The paper does not address boundary condition tuning, outlet resistance, Windkessel parameters, or any statement that tuning compensates for geometric error.
- **Q-D fidelity / quantity**: NOT REPORTED. The paper is clinical/AI-focused and does not report reduced-order (0D/1D) or 3D CFD modeling, WSS, OSI, or spatially-resolved hemodynamic fields.
- **Q-E data**: Mixed public/private datasets. 128 studies reviewed; mentions multi-center collaborations and federated learning across 38 institutions; invasive FFR ground truth NOT explicitly reported as present.
- **Q-F meshing**: NOT REPORTED. No discussion of segmentation-to-surface-to-volume meshing pipelines, robustness to topologically incorrect geometry, or segmentation quality gates.

## Novelty bearing on T6
- bucket: BACKGROUND
- one-line reason: Comprehensive review of AI in cerebrovascular disease, covering risk prediction and diagnostic optimization but not addressing digital twin validation frameworks, boundary condition tuning, or the specific concern that parameter fitting can mask topological segmentation errors.
- verdict: LIGHT
- revisit-if: Paper incorporates case studies demonstrating that model re-tuning after geometry change absorbs segmentation error, or provides quantitative evidence of decision-flip sensitivity to segmentation perturbations
